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INTRODUCTION
HYPOTHESIS
Saffron was expected to have antitumor activity in MDA468 
breast carcinoma cells
METHODS
Saffron decreases cell viability in a time and dose dependent manner
Saffron induces marked reduction in tumorigenicity of MDA468 cells
Increasing saffron concentration causes a decrease in breast cancer cell 
invasion potential
CONCLUSIONS
• Increasing concentrations of saffron cause a 
decrease in cell motility
• Cell viability decreases as saffron concentration 
increases.
• Cell invasion potential decreases as saffron 
concentrations increase.
• Saffron causes a decrease in tumorgenicity.
FUTURE DIRECTIONS
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Increasing saffron results in a decrease in cell motility 
and invasion potential
Figure 5A) The reduction of cell 
projections in a time dependent manner 
after the addition of Saffron as shown by 
video produced by Q-Phase. 
5B) Comparison of cells migrated across 
Boyden chamber membrane with bovine 
serum albumin  (BSA) ss a positive 
control after 12 hours of saffron 
treatment.
5C) Comparison of migration distance 




Figure 2A) Comparison of cell confluency at 100x and 400x magnification. 2B) Percentage of normal, stalled, 
multinucleated, and apoptotic cells between 0-72 hours. 2C) Percentage cell death calculated by trypan blue 
assay between 24-72 hours. 2D) Percentage fold changes in mass in control and saffron groups as per Q-phase 
analysis. 2E) Comparison of percentage cellular apoptosis between 24-72 hours.
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Figure 4A) Morphological 
comparison between control versus 
saffron treated MDA-MB-468 
breast cancer cells at 0 and 12 -
hour time periods. White arrows 
mark cell projections. 
4B) Average distance traveled by 
cells over a 12-hour time period, as 
calculated by Q-Phase Analysis. 
Cells were split into three groups 
based on movement: Non-Motile 
(10-35µm), Low-Motile (35-
150µm), and High-Motile (150-





Figure 1.  Comparison 
of relative growth as 
per crystal violet cell 
viability assay.
Table 1. Concentration 

























isolatable colonies at 
400x magnification on 
final day of saffron 
treatment. 
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• Analysis of saffron’s effectiveness against motility, cell 
viability, cell invasion potential, and tumorgenicity for 
increased duration of time.
• Further exploration of saffron as an alternative therapy 
for breast cancer carcinoma in an animal model.














































Untreated (UT) 0 ug/ mL
Saffron Low (SL) 100 ug/ mL
Saffron Medium (SM) 250 ug/mL
Saffron High (SL) 500 ug/ mL
